Donaco International Statistics

Total Valuation

ASX:DNA has a market cap or net worth of AUD 51.83 million. The enterprise value is 35.86 million.

Market Cap	51.83M
Enterprise Value	35.86M

Important Dates

The next estimated earnings date is Wednesday, May 28, 2025.

Earnings Date	May 28, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:DNA has 1.23 billion shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class	1.23B
Shares Outstanding	1.23B
Shares Change (YoY)	+0.08%
Shares Change (QoQ)	-0.05%
Owned by Insiders (%)	48.97%
Owned by Institutions (%)	1.97%
Float	495.45M

Valuation Ratios

The trailing PE ratio is 1.32.

PE Ratio	1.32
Forward PE	n/a
PS Ratio	1.24
PB Ratio	0.29
P/TBV Ratio	0.32
P/FCF Ratio	3.08
P/OCF Ratio	2.91
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 1.50, with an EV/FCF ratio of 2.13.

EV / Earnings	0.92
EV / Sales	0.86
EV / EBITDA	1.50
EV / EBIT	2.02
EV / FCF	2.13

Financial Position

The company has a current ratio of 1.02, with a Debt / Equity ratio of 0.11.

Current Ratio	1.02
Quick Ratio	0.98
Debt / Equity	0.11
Debt / EBITDA	0.79
Debt / FCF	1.12
Interest Coverage	9.96

Financial Efficiency

Return on equity (ROE) is 26.79% and return on invested capital (ROIC) is 6.38%.

Return on Equity (ROE)	26.79%
Return on Assets (ROA)	5.44%
Return on Invested Capital (ROIC)	6.38%
Return on Capital Employed (ROCE)	9.49%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.21
Inventory Turnover	19.02

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +5.00% in the last 52 weeks. The beta is 0.79, so ASX:DNA's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	+5.00%
50-Day Moving Average	0.04
200-Day Moving Average	0.03
Relative Strength Index (RSI)	51.79
Average Volume (20 Days)	1,415,235

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:DNA had revenue of AUD 41.91 million and earned 39.13 million in profits. Earnings per share was 0.03.

Revenue	41.91M
Gross Profit	27.58M
Operating Income	17.73M
Pretax Income	39.43M
Net Income	39.13M
EBITDA	23.17M
EBIT	17.73M
Earnings Per Share (EPS)	0.03

Full Income Statement

Balance Sheet

The company has 36.26 million in cash and 18.92 million in debt, giving a net cash position of 17.34 million or 0.01 per share.

Cash & Cash Equivalents	36.26M
Total Debt	18.92M
Net Cash	17.34M
Net Cash Per Share	0.01
Equity (Book Value)	178.79M
Book Value Per Share	0.14
Working Capital	900,662

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 17.83 million and capital expenditures -999,089, giving a free cash flow of 16.83 million.

Operating Cash Flow	17.83M
Capital Expenditures	-999,089
Free Cash Flow	16.83M
FCF Per Share	0.01

Full Cash Flow Statement

Margins

Gross margin is 65.81%, with operating and profit margins of 42.30% and 93.36%.

Gross Margin	65.81%
Operating Margin	42.30%
Pretax Margin	94.08%
Profit Margin	93.36%
EBITDA Margin	55.27%
EBIT Margin	42.30%
FCF Margin	40.15%

Dividends & Yields

ASX:DNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.08%
Shareholder Yield	-0.08%
Earnings Yield	75.49%
FCF Yield	32.47%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:DNA has an Altman Z-Score of -0.56. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.56
Piotroski F-Score	n/a